NASDAQ · ORMP
Oramed Pharmaceuticals Inc.
$4.23+$0.07 (+1.68%)
Oramed Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.67% below the high.
Loading market information…
TLV · BVC.TA · ILA
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
BATM Advanced Communications Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
BATM Advanced Communications Ltd.’s next earnings report is currently expected on Mar 17, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow BATM Advanced Communications Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
BATM Advanced Communications Ltd., alongside its affiliated companies, specializes in the innovation, production, and commercialization of cutting-edge real-time technologies throughout Israel, the United States, and Europe. The enterprise conducts its operations through two distinct divisions: Networking and Cybersecurity, and Bio-Medical. The Networking and Cybersecurity division is responsible for the research, development, manufacturing, and market introduction of various data communication products. These offerings encompass technologies such as network function virtualization, edge computing, carrier ethernet, MPLS access solutions, advanced cyber network monitoring, and robust network encryption. Additionally, this segment delivers a range of software services, including user training, technical support, laboratory assistance, and ongoing maintenance, as well as undertaking construction contracts. Conversely, the Bio-Medical division focuses on delivering molecular biology diagnostic tools and provides comprehensive solutions for managing and neutralizing hazardous pathogenic and medical waste generated in environments like laboratories, hospitals, pharmaceutical production facilities, and agricultural settings. This segment also performs diverse testing services and serves as a distributor for a wide array of diagnostic apparatus and medical consumables from various brands. Established in 1992, BATM Advanced Communications Ltd. maintains its principal corporate office in Hod Hasharon, Israel.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$4.23+$0.07 (+1.68%)
Oramed Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.67% below the high.
₪0.18+₪0.00 (+0.57%)
Bonus BioGroup Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.1% below the high.
₪13.68+₪0.29 (+2.17%)
InterCure Ltd.’s quoted price sits in the upper half of its reported 52-week range, 43.55% below the high.
₪10.29+₪0.09 (+0.88%)
Golden House Ltd’s quoted price sits in the lower half of its reported 52-week range, 17.68% below the high.
₪1.11₪0.00 (0.0%)
Dna Group (T.R.) Ltd’s quoted price sits in the lower half of its reported 52-week range, 26.8% below the high.
₪10.20₪0.00 (0.0%)
Rekah Pharmaceutical Industry Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
₪3.49+₪0.25 (+7.75%)
Epitomee Medical Ltd’s quoted price sits in the lower half of its reported 52-week range, 66.73% below the high.
₪9.48+₪0.08 (+0.81%)
Nissan Medical Industries Ltd’s quoted price sits in the upper half of its reported 52-week range, 15.6% below the high.